Skip to main content
NIH funding notice PAR-18-494

Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional)

Closed on July 24, 2020.

Posted
December 15, 2017
Close date
July 24, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,881,904 in first-year total cost, median $369,117.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 JXB-N (05)]3
  2. Special Emphasis Panel[ZDA1 IXN-O (14)]2
  3. Special Emphasis Panel[ZDA1 JXB-N (08)]2

Most frequent institutions

  1. MEDICAL UNIVERSITY OF SOUTH CAROLINA2
  2. BUTLER HOSPITAL (PROVIDENCE, RI)1
  3. EMORY UNIVERSITY1
  4. UNIVERSITY OF MARYLAND BALTIMORE1
  5. UNIVERSITY OF MINNESOTA1
Competing awards under PAR-18-494 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021RTMS manipulates imbalanced drive-reward and executive control circuitry for smoking cessation1UG3DA048507-01A1LI, XINGBAOMEDICAL UNIVERSITY OF SOUTH CAROLINA, SC$355,815ZDA1
2020Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders1UG3DA048502-01A1BREMNER, JAMES DOUGLASINAN, OMER TOLGAEMORY UNIVERSITY, GA$739,505ZDA1
2019Examining the effects of Theta Burst Stimulation on corticothalamic mediated inhibitory control and smoking relapse vulnerability.1UG3DA048510-01FROELIGER, BRETTMEDICAL UNIVERSITY OF SOUTH CAROLINA, SC$373,744ZDA1
2019Combined tDCS and Cognitive Training for the Treatment of Opioid Addiction1UG3DA048508-01LIM, KELVIN O.UNIVERSITY OF MINNESOTA, MN$358,820ZDA1
2018Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder1UG3DA047714-01REZAI, ALI RWEST VIRGINIA UNIVERSITY, WV$375,000ZDA1
2018Circuitry-Guided Smoking Cessation in Schizophrenia1UG3DA047685-01DU, XIAOMINGHONG, L ELLIOT ELLIOTUNIVERSITY OF MARYLAND BALTIMORE, MD$369,117ZDA1
2018tDCS to Decrease Opioid Relapse1UG3DA047793-01ABRANTES, ANA MSTEIN, MICHAEL DBUTLER HOSPITAL (PROVIDENCE, RI), RI$309,903ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-494: Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional) | ScienceDex | ConductScience